Article Text

Download PDFPDF
Original research
Implications of the use of mechanical thrombectomy on outcome in large vessel occlusion following the 2015 landmark trials
  1. Okkes Kuybu1,
  2. Vijayakumar Javalkar1,
  3. Abdallah Amireh1,
  4. Arshpreet Kaur2,
  5. Roger E Kelley1,
  6. Hugo H Cuellar-Saenz3,
  7. Pankaj Sharma1,3
  1. 1 Department of Neurology, LSU Health Shreveport, Shreveport, Louisiana, USA
  2. 2 Department of Endocrinology, LSU Health Shreveport, Shreveport, Louisiana, USA
  3. 3 Department of Neurosurgery, LSUHSC, Shreveport, Louisiana, USA
  1. Correspondence to Dr Pankaj Sharma, Department of Neurology, LSU Health Shreveport, Shreveport, LA 71130, USA; drpasharma{at}gmail.com

Abstract

Background The effectiveness of mechanical thrombectomy (MT) was demonstrated in five landmark trials published in2015.Mechanical thrombectomy is now standard of care for acute ischemic stroke and has been growing in popularity after publication of landmark trials.

Objective To analyze outcomes and trends of the use of MT and intravenous thrombolysis (IVT) in patients with acute ischemic stroke in US hospitals before and after publication of these trials.

Methods Patients discharged with a diagnosis of ischemic stroke between 2012 to 2017 were diagnosed using ICD codes from the National Inpatient Sample. Thereafter, patients given acute stroke treatment were identified using the corresponding procedure codes for IVT and MT. The primary clinical outcomes of in-hospital mortality and disability were then compared between two time periods: 2012–2014 (pre-landmark trials) and 2015–2017 (post-landmark trials). Binary logistic regression and Χ2 tests were used for statistical analysis.

Results A total of 57 675 patients (median age 68.9 years (range 18-90), 50.1% female) were identified with acute procedures. Of these patients, 57.6% were from the post-landmark trials time period. Despite an increased number of cases, the rate of IVT decreased from 84.3% to 75.9% and the rate of IVT+MT decreased from 7.1% to 6.3%. After publication of the pivotal trials in 2015, the rates of MT increased from 8.7% to 17.8%. Significant reductions of in-hospital mortality (7.1% vs 8.7%, p<0.001) and disability (64% vs 66.2%, p<0.001) were noted.

Conclusion The analysis showed a significant increase in the proportion of patients receiving MT after 2015. This has translated into reduction of in-hospital mortality and improvement in disability.

  • thrombectomy
  • stroke
  • thrombolysis
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors OK, V, PSJ: designed and conceptualized the study; analyzed the data; drafted and revised the manuscript for intellectual content. AA, REK, HHC-S: interpreted the data; revised the manuscript for intellectual content. AK: interpreted the data.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study did not require ethics approval for research using the HCUP-NIS database, as it is a de-identified publically available dataset.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data may be obtained from a third party and are not publicly available. National Inpatient Sample dataset.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.